Spiro-piperidine derivatives
US7495008B2 · kind B2 · utility
1Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2007 |
| Grant date | Feb 24, 2009 |
| Priority date | — |
| Expiry date | Dec 13, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with novel spiro-piperidine derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases.In particular, the present invention is concerned with compounds of the general formula (I)wherein R1 to R5, R5′, X, Y and A are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.